Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by Rossaporinoon Jan 30, 2022 2:19pm

T cell

https://www.marketwatch.com/press-release/shortages-of-covid-19-tests-creates-accelerated-demand-for-new-diagnostic-technology-2021-11-09-101971242
140
Post by Rossaporinoon Jan 30, 2022 1:13pm

No hype it’s just fact

https://www.labmedica.com/covid-19/articles/294790222/worlds-first-low-cost-disposable-covid-19-diagnostic-test-to-identify-t-cell-immune-response-to-sars-cov-2.html
124
Post by Rossaporinoon Jan 29, 2022 12:27am

T cell

https://consumer.healthday.com/b-1-27-beyond-antibodies-vaccines-teach-your-immune-t-cells-to-fight-covid-long-term-2656474938.html
162
Comment by SnowBall123on Jan 28, 2022 6:27pm

RE:Here is a twist to the covid diagnostic tool

Talking with less requirement countries isn't new, he said that many times in other interviews. Did he say what stage they're in for the talk?
73
Discussion
Post by frankmanon Jan 28, 2022 3:41pm

Here is a twist to the covid diagnostic tool

Just got off the phone. They are also exploring a licensing deal with a royalty with other countries. The skin test faces less requirements in some counties. The only other known test requires a ...more  
235
Discussion
Post by terryowon Jan 28, 2022 11:52am

They are quite slim .19 up

The anon 20k ask they bought at .18 a few days ago and keeps pulling so they are welcome to sell at a loss. Lokk at the nothing shares behind. 0.20 2,500 1  ...more  
92
Post by moneywagonon Jan 28, 2022 10:38am

BIOV GET THE POPCORN NEW 52 WK LOW @175 SHORT MAKE MONEY

KEEP the pressure shorts Symbol Issue Name Shares Net Change Date $BIOV.CN BIOVAXYS TECHNOLOGY CORP. 133,866 76,103  ...more  
101
Comment by annwarwon Jan 27, 2022 2:42pm

RE:RE:RE:On that note BIOV will start human tumour trials

FDA is only looking at minimal factors as it only involves sample taking.
71
Discussion
Comment by annwarwon Jan 27, 2022 2:37pm

RE:RE:On that note BIOV will start human tumour trials

I think it might be the FDA approval of the covid diagnostic tool. A formality.
73
Discussion
Post by terryowon Jan 27, 2022 2:04pm

Now gap up to .195 .20

0.20 12,500 2 0.195 2,500 2 0.185 500 1
70
Comment by cindfx1on Jan 27, 2022 12:39pm

RE:On that note BIOV will start human tumour trials

Yes we are due for the clean room update along with a couple of other updates.
50
Discussion
Post by terryowon Jan 27, 2022 10:20am

Asks .195 .20

0.20 2,500 1 0.195 4,500 2
68
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities